<DOC>
	<DOCNO>NCT00603343</DOCNO>
	<brief_summary>The study conduct 2004 2006 prove efficacy tolerability antimuscarinic propiverine compare placebo child suffer non-neurogenic overactive bladder urinary incontinence .</brief_summary>
	<brief_title>Propiverine Children Suffering From Non-Neurogenic Overactive Bladder Urinary Incontinence</brief_title>
	<detailed_description>This clinical trial show superior efficacy propiverine placebo convince tolerability treatment child suffer OAB urinary incontinence .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Propiverine</mesh_term>
	<criteria>void frequency 8 per day least one incontinence episode per day age 510 year body weight 17 45 kg normal age expect bladder capacity PVR 10 ml dysfunctional voiding neurogenic disorder UTI , constipation</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>antimuscarinics</keyword>
	<keyword>child</keyword>
	<keyword>overactive bladder</keyword>
	<keyword>propiverine</keyword>
	<keyword>urinary incontinence</keyword>
	<keyword>urotherapy</keyword>
</DOC>